1-20 of 648
non-hodgkin's lymphoma, aggressive
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

T Cell Determinants of Response and Resistance to PD-1 Blockade in Richter's Transformation

Free
Erin Parry, MD PhD, Camilla K Lemvigh, MSc, Annabelle J Anandappa, MD, Shuqiang Li, PhD, Lillian Werner, MS, Ana Lako, Noelia Purroy, MD PhD, Satyen H Gohil, PhD, M.B.,B.S., Giacomo Oliveira, PhD, Pavan Bachireddy, MD, Teddy Huang, Ignaty Leshchiner, PhD, Aina Zurita Martinez, Lars Ronn Olsen, PhD, Kenneth Livak, PhD, Gad Getz, PhD, Donna S Neuberg, ScD, Scott J Rodig, MD PhD, William G. Wierda, MD PhD, Peter Kharchenko, PhD, Nitin Jain, MD, Catherine J. Wu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 680.
https://doi.org/10.1182/blood-2019-125904
Published: 2019
Journal Articles

Short-Course Therapy in Newly Diagnosed Immunodeficiency-Associated Aggressive B-Cell Lymphoma

Free
Rami Alsharif, MD, Samah Nassereddine, MD, Esma Akin, MD, Donald Karcher, MD, Mitchell Smith, MD PhD, Eduardo Sotomayor, MD, Kieron Dunleavy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5355.
https://doi.org/10.1182/blood-2019-124081
Published: 2019
Journal Articles

Hexokinase II Expression As a Prognosis Marker in Diffuse Large B-Cell Lymphoma (DLBCL) Pre- and Post- the Incorporation of Rituximab to Standard CHOP Chemotherapy

Free
Juan J. Gu, MD PhD, Yizhen Liu, MD PhD, Jia Jin, Ling Yang, Zuguang Xia, Xiaojian Liu, Fangfang Lv, MD, Francisco J. Hernandez-Ilizaliturri, MD, Xiaonan Hong, Junning Cao, MD, Qunling Zhang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5233.
https://doi.org/10.1182/blood-2019-128878
Published: 2019
Journal Articles

Optimize the Patient to Optimize the Therapy: Role of Prephase Cyclophosphamide in Aggressive Lymphoma

Free
Nabin Karki, MBBS, Vamsi Kota, MBBS, Katherine Saunders, PharmD, Cara Iacobellis, PharmD, Anand Jillella, MD, Germame Ajebo, MD, Locke J. Bryan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5294.
https://doi.org/10.1182/blood-2019-129644
Published: 2019
Journal Articles

Prophylactic Use of Filgrastim on Days 7, 11 and 14 in Patients Receiving R-CHOP for Non-Hodgkin's Lymphoma

Free
Sherief El- Shakankery, MPharm, Sumantha Gabriel, BPharm, Emma Groves, M Pharm
Journal: Blood
Blood (2019) 134 (Supplement_1): 5887.
https://doi.org/10.1182/blood-2019-124329
Published: 2019
Journal Articles

Beyond Acute Leukemia: Learner Perceptions of Inpatient Hematology Education and Deficiencies in Non-Malignant Topics

Free
Andrew O'Brien, MD, Rakesh P. Mehta, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5797.
https://doi.org/10.1182/blood-2019-123271
Published: 2019
Journal Articles

Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation for Patients with Richter's Syndrome: A Large Series from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Free
Olivier Tournilhac, MD PhD, Romain Guièze, MD PhD, Dirk-Jan Eikema, Nienke Zinger, Henrik Sengeloev, MD DMSc, Jakob R. Passweg, MD, Bendt Nielsen, Xavier Poire, Jenny Byrne, MD PhD, Martin Gramatzki, MD, Jürgen Finke, MD, Jan J Cornelissen, MD PhD, D Blaise, Emmanouil Nikolousis, MDPhDMRCP FRCPath, Patrice Chevallier, MD, Gwendolyn Van Gorkom, Mark Ringhoffer, MD, Nicola Mordini, Liesbeth C. de Wreede, PhD, Patrick John Hayden, BA, Michel van Gelder, MD PhD, Ibrahim Yakoub-Agha, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2053.
https://doi.org/10.1182/blood-2019-129949
Published: 2019
Journal Articles

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Free
Ga-Young Song, Seok Jin Kim, MD PhD, Sang Eun Yoon, Jin Seok Kim, MD PhD, Ho-Young Yhim, MD PhD, Youngil Koh, MD PhD, Sung Yong Oh, MD PhD, Ho Sup Lee, MD PhD, Ho-Jin Shin, MD PhD, Young Rok Do, MD PhD, Won Sik Lee, MD PhD, Lee Gyeong-Won, Dae Sik Kim, Yong Park, Deok-Hwan Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4002.
https://doi.org/10.1182/blood-2019-126574
Published: 2019
Journal Articles

Results of a Phase I Study of Obinutuzumab, Venetoclax, and Lenalidomide in Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Free
Beth A. Christian, MD, Ying Huang, MS, MA, Sabarish Ayyappan, MBBS, Robert A Baiocchi, MD PhD, Jonathan E Brammer, MD, Narendranath Epperla, MDMS, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Farrukh T. Awan, MD, Kami J. Maddocks, MD, Kristie A. Blum, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4082.
https://doi.org/10.1182/blood-2019-126242
Published: 2019
Journal Articles

IgM-Gammopathies Transformed into Aggressive Lymphoma: Incidence, Basal Clinical Features and Outcome of a Registry Based, Spanish Retrospective Series

Free
Irene Dogliotti, MD, Cristina Jiménez, PhD, Federica Cavallo, MD PhD, Noemi Puig, MD PhD, Gian Maria Zaccaria, PhD, Veronica Gonzalez De La Calle, MD PhD, Maria Eugenia Sarasquete, PhD, Miguel Alcoceba, Pilar Delgado, MD, Maria Rosa López, MD, Aránzazu García Mateo, PhD, Simone Ferrero, MD, Mario Boccadoro, Marcos González, Ramón García-Sanz, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4011.
https://doi.org/10.1182/blood-2019-123353
Published: 2019
Journal Articles

Analysis of a Safety Run-in Cohort from Niveau, a Phase 3 Study for Patients with Aggressive Non-Hodgkin Lymphoma in First Relapse or Progression Not Eligible for High-Dose Chemotherapy (HDT), Testing Nivolumab in Combination with Gemcitabine, Oxaliplatin (GemOx) Plus Rituximab (R) in Case of B-Cell Lymphoma

Free
Gerhard Held, MD, Corinne Haioun, MD PhD, Roch Houot, MD PhD, Philippe Gaulard, MD PhD, Thierry Molina, Andreas Rosenwald, MD, Marc André, Joerg Hoffmann, MD, Martin Dreyling, MD, Olivier Casasnovas, MD, Herve Maisonneuve, MD, Herve Tilly, MD PhD, Thomas Illmer, Stephanie Mayer, MD, Heinz Kirchen, MD, Paul La Rosée, MD, Markus Loeffler, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Viola Poeschel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4085.
https://doi.org/10.1182/blood-2019-129347
Published: 2019
Journal Articles

The Use of CEP (Lomustine, Etoposide and Prednisone), an All-Oral Palliative Chemotherapy Regimen, in Aggressive Lymphomas

Free
Lakshman Vasanthamohan, MD FRCPC, Brent Parker, MD, Joy Mangel, MD FRCPC, Selay Lam, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Chai Wye Phua, MD FRCPC
Journal: Blood
Blood (2019) 134 (Supplement_1): 4131.
https://doi.org/10.1182/blood-2019-126997
Published: 2019
Journal Articles

Splenic Marginal Zone Lymphoma: Risk of Transformation, Clinico-Biological Features at Transformation and Prognosis

Free
Gabriela Bastidas, MD, Silvia Bea, PhD, Alba Navarro, Eva Gine, MD, Julio Delgado, Tycho Baumann, Alfredo Rivas-Delgado, MD, Laura Magnano, MD, Neus Villamor, Dolors Costa, MD, Colomer Dolors, Monica Lopez-Guerra, María Rozman, MD, Daniel Martínez, MD, Balagué Olga, Maria Joao Baptista, PhD PharmD, Miguel Alcoceba, Lourdes Escoda, MD, Andrew Wotherspoon, MB BCh, Elias Campo, Armando Lopez-Guillermo, Estella Matutes, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4015.
https://doi.org/10.1182/blood-2019-127199
Published: 2019
Journal Articles

Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory Lymphomas

Free
Paolo F Caimi, MD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Dina Schneider, PhD, Kristen Bakalarz, CNP, Kirsten M Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MD PhD, Erin Galloway, RN BSN, Winfried Kruger, Andrew Worden, Michael Kadan, Filipa Blasco Lopes, Ashish Sharma, Ehsan Malek, MD, Leland Metheny, III, MD, Seema Patel, PharmD, Benjamin K. Tomlinson, MD, David Wald, MD PhD, Rafick-Pierre Sekaly, Rimas Orentas, PhD, Boro Dropulic, PhD, Marcos de Lima, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4074.
https://doi.org/10.1182/blood-2019-131300
Published: 2019
Journal Articles

Peak Lymphocyte Count after CAR T Infusion Is a Clinically Accessible Test That Correlates with Clinical Response in Axicabtagene Ciloleucel Therapy for Lymphoma

Free
Mattia Novo, M Hasib Sidiqi, MBBS, Jonas Paludo, MD, Sangeetha Gandhi, MBBS, Jilan Kubusek, PharmD, Tuan Truong, Justin Hayne, Stephen M Ansell, MD PhD, N. Nora Bennani, MD, Jose C Villasboas, Adrienne Nedved, Pharm.D., R,Ph, Gina Lange, Eva Brandes, Hassan B. Alkhateeb, MD, David Dingli, MD PhD, Suzanne R. Hayman, MD, Prashant Kapoor, MD, Saad S. Kenderian, MD, Taxiarchis Kourelis, MD, Shaji K. Kumar, MD, Mithun Vinod Shah, MD PhD, Mustaqeem Siddiqui, MD, Rahma M Warsame, MD, Patrick Johnston, MD PhD, Yi Lin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4106.
https://doi.org/10.1182/blood-2019-127094
Published: 2019
Journal Articles

Early Organ Toxicity Following Allogeneic Hematopoietic Stem Cell Transplantation Differs By Conditioning Regimen

Free
Joshua A Fein, MD, Avichai Shimoni, MD, Ivetta Danylesko, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Guy Chowers, MD, Zachary Cohen, Arnon Nagler, MD MSc, Roni Shouval
Journal: Blood
Blood (2019) 134 (Supplement_1): 4489.
https://doi.org/10.1182/blood-2019-126325
Published: 2019
Journal Articles

Glycolytic Biomarkers Predictive of Transformation in Patients with Follicular Lymphoma

Free
Ida Monrad, MSc, Charlotte Madsen, Kristina Lauridsen, Bent Honoré, Trine Lindhardt Plesner, Stephen Hamilton-Dutoit, MD, Francesco d'Amore, MD, Maja Ludvigsen, MSc, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2805.
https://doi.org/10.1182/blood-2019-122651
Published: 2019
Journal Articles

PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Free
Mark Roschewski, MD, Raquel Izumi, PhD, Ahmed Hamdy, MD, Manish R. Patel, MD, Hendrik-Tobias Arkenau, MD PhD, Sven de Vos, MD PhD, Patrick M Reagan, MD, Pier Luigi Zinzani, MD PhD, Andrew Davies, MD PhD, John M Pagel, MD PhD, Julie M Vose, MDMBA, Bojena Bitman, Graham Brock, PhD, Edwin Clark, PhD, Melanie M. Frigault, PhD, Joseph Ware, PhD, Buyue Yang, MD PhD, Wyndham Wilson, MD, Louis Staudt, MD, Ian W. Flinn, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2869.
https://doi.org/10.1182/blood-2019-125939
Published: 2019
Journal Articles

Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS)

Free
Tiziana Vaisitti, PhD, Katti Jessen, PhD, Thanh-Trang Vo, PhD, Mira Ko, Francesca Arruga, PhD, Nicoletta Vitale, PhD, Esteban Braggio, PhD, Arianna Di Napoli, Amy Chadburn, MD, John N. Allan, MD, Richard R. Furman, MD, Langdon L. Miller, Brian J Lanutti, PhD, Silvia Deaglio, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2856.
https://doi.org/10.1182/blood-2019-126827
Published: 2019
Journal Articles

Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma

Free
Dominic Kaddu-Mulindwa, MD, Bettina Altmann, PhD, Gerhard Held, MD, Marita Ziepert, PhD, Karin Menhart, MD, Jirka Grosse, MD, Stephanie Angel, Stephan Stilgenbauer, Michael Pfreundschuh, MD, Ken Herrmann, MD PhD, Ulrich Duehrsen, MD, Andreas Hüttmann, MD, Francesco Barbato, Dirk Hellwig, Viola Poeschel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2892.
https://doi.org/10.1182/blood-2019-128896
Published: 2019